REFSAV 50 TABLET is a combination of Sacubitril and Valsartan which belongs to the group of medicines called Angiotensin receptor neprilysin inhibitors. REFSAV 50 TABLET is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (New York Heart Association Class II-IV) and reduced ejection fraction.  

Heart failure occurs when the heart is weak and cannot pump enough blood to the lungs and to the rest of the body and it is characterized by symptoms such as breathlessness, fatigue, tiredness and ankle swelling. Before taking REFSAV 50 TABLET inform your doctor if you have liver, kidney or heart problems. REFSAV 50 TABLET is not recommended for use in pregnant and breast-feeding women. It is not suitable for use in children and adolescents under 18 years of age and it should be used with caution in elderly patients (65 years of age and above).    

Before taking REFSAV 50 TABLET inform your doctor about previous allergy and medication history to manage any serious effect. The most common side effects of taking REFSAV 50 TABLET are dizziness, cough, headache, tiredness, nausea and weakness. Consult your doctor if any of the side effects worsen.